Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.26 USD
Change Today +0.07 / 0.76%
Volume 5.7K
MSON On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

misonix inc (MSON) Snapshot

Open
$9.17
Previous Close
$9.19
Day High
$9.29
Day Low
$9.16
52 Week High
10/28/14 - $14.90
52 Week Low
08/7/14 - $6.01
Market Cap
71.4M
Average Volume 10 Days
7.8K
EPS TTM
$0.36
Shares Outstanding
7.7M
EX-Date
--
P/E TM
25.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for MISONIX INC (MSON)

Related News

No related news articles were found.

misonix inc (MSON) Related Businessweek News

No Related Businessweek News Found

misonix inc (MSON) Details

Misonix, Inc., a surgical device company, designs, develops, manufactures, and markets minimally invasive ultrasonic surgical device products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications. The company offers BoneScalpel cutting system that is used for surgical procedures of the spine and in maxillofacial procedures; SonaStar surgical aspirator, which is used to emulsify and remove soft and hard tumors; and SonicOne wound cleansing and debridement system for the removal of devitalized tissue and fibrin deposits while sparing viable cells. It also markets AutoSonix ultrasound cutting and coagulating system that is used for various laparoscopic surgical procedures. The company sells its products through direct sales persons, sales agents, and distributors. It has operations in the United States, Australia, Europe, Asia, Canada, Mexico, South America, South Africa, and the Middle East. The company was founded in 1959 and is based in Farmingdale, New York.

68 Employees
Last Reported Date: 09/17/14
Founded in 1959

misonix inc (MSON) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $388.9K
Chief Financial Officer, Senior Vice Presiden...
Total Annual Compensation: $244.5K
Vice President of Research & Development and ...
Total Annual Compensation: $176.0K
Vice President of Global Sales and Marketing
Total Annual Compensation: $203.0K
Compensation as of Fiscal Year 2014.

misonix inc (MSON) Key Developments

Misonix, Inc. Unveils New SonicOne O.R. App to Highlight Advantages of Ultrasonic Wound Debridement in Acute and Chronic Wounds

Misonix, Inc. announced the launch of its SonicOne O.R. app for iPad mobile devices. The new iPad app was designed to educate users on the extensive benefits of ultrasonic wound debridement using the SonicOne technology. Users can explore the science behind the SonicOne O.R. with 3D animation of the innovative ultrasound technology, witness the macro and microscopic interaction of ultrasound in a wound environment, and observe the surgical technique used for debriding a wound in the 3D wound animation. The app also contains extensive material on SonicOne O.R.'s clinical and economic benefits, key publications and endorsements from distinguished surgeons who have made SonicOne a standard of care in their practice.

Misonix, Inc. Launches Faster Faster SonicOne Ultrasonic Debridement Procedure

Misonix, Inc. announced that it has released a newly-developed, faster SonicOne O.R. Ultrasonic wound debridement procedure. The procedure is enabled by a new single-use disposable debridement probe with increased ultrasonic amplitude that allows surgeons using the SonicOne device to potentially reduce the operating room time necessary to complete a procedure by up to 50%. The SonicOne O.R. System is an innovative ultrasonic surgical debridement system that allows surgeons to address the challenges chronic wounds present to them, the patient and the health-care system. SonicOne O.R. establishes a new standard in surgical wound bed preparation, an essential first step in the wound healing process. The new SonicOne procedure will be sold and distributed through the Misonix sales team and the company's distributor network in the United States.

Misonix, Inc. Introduces the New 25-Millimeter Blade to the Bonescalpel™ Portfolio

Misonix, Inc. released its newly-developed 25mm BoneScalpel blade. The new 25mm BoneScalpel blade now offers surgeons the tool to access previously unreachable anatomy as well as facilitates the cutting and removal of larger boney structures. The BoneScalpel is an ultrasonic bone-cutting instrument that provides surgeons a clean, controlled bone incision and removal that is also soft-tissue sparing.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MSON:US $9.26 USD +0.07

MSON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bovie Medical Corp $2.09 USD +0.03
IRIDEX Corp $6.91 USD -0.09
MGC Diagnostics Corp $5.04 USD +0.0172
NanoVibronix Inc $4.00 USD 0.00
Utah Medical Products Inc $53.82 USD +0.43
View Industry Companies
 

Industry Analysis

MSON

Industry Average

Valuation MSON Industry Range
Price/Earnings 25.9x
Price/Sales 3.4x
Price/Book 3.7x
Price/Cash Flow 22.7x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MISONIX INC, please visit www.misonix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.